Drawing for HYDIZYME

USPTO serial 79418074

HYDIZYME

Reviewed by CopyMark Law Group

Reg. 8122589Status 700Registered
Filing date
Status date
Registration date
Feb 3, 2026
Examiner
WILLIS, ALLYSON B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HYDIZYME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R Menker

James R Menker Holley & Menker, PA60 Ocean Boulevard, Suite 3Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; enzymes for veterinary purposes; ferments for pharmaceutical purposes; pharmaceutical agents for epidermis; cellular function activating agents for medical purposes; medicinal creams for skin care; enzymes for medical purposes; enzyme preparations for medical purposes; medicines for human purposes, namely, drug delivery agents in liquid form for subcutaneous administration that facilitate the delivery of pharmaceutical preparations; enzyme preparations for medical purposes containing recombinant human hyaluronidase as an active ingredient; enzymes for medical purposes containing recombinant human hyaluronidase; medicated skin care preparations.ACTIVE—
042Research and development of siRNA drugs; scientific research; research and development of vaccines and medicines; biomedical research services; drug discovery services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research services; research on the subject of pharmaceuticals; development of gene-based medicines; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; consultancy in the field of testing, inspection, research of medical products; medical research services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 13, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 7, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 7, 2026FIMPFINAL DISPOSITION PROCESSED—
Jul 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 26, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 3, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 14, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 7, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 6, 2025RFRRREFUSAL PROCESSED BY MPU—
Jun 18, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2025DOCKASSIGNED TO EXAMINER—
Mar 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance